Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival After Relapse of Medulloblastoma.
Koschmann C, Bloom K, Upadhyaya S, Geyer JR, Leary SE. Koschmann C, et al. Among authors: upadhyaya s. J Pediatr Hematol Oncol. 2016 May;38(4):269-73. doi: 10.1097/MPH.0000000000000547. J Pediatr Hematol Oncol. 2016. PMID: 26907655
Brainstem Low-Grade Gliomas in Children-Excellent Outcomes With Multimodality Therapy.
Upadhyaya SA, Koschmann C, Muraszko K, Venneti S, Garton HJ, Hamstra DA, Maher CO, Betz BL, Brown NA, Wahl D, Weigelin HC, DuRoss KE, Leonard AS, Robertson PL. Upadhyaya SA, et al. J Child Neurol. 2017 Feb;32(2):194-203. doi: 10.1177/0883073816675547. Epub 2016 Nov 3. J Child Neurol. 2017. PMID: 27810966 Free PMC article.
Treatment-related calvarial lesions in pediatric brain tumor survivors.
Wallace D, Taylor DR, Pan H, Hwang S, Lucas JT Jr, Klimo P Jr, Upadhyaya SA, Boop FA. Wallace D, et al. Among authors: upadhyaya sa. Pediatr Blood Cancer. 2020 Jun;67(6):e28189. doi: 10.1002/pbc.28189. Epub 2020 Apr 14. Pediatr Blood Cancer. 2020. PMID: 32286018 Free PMC article.
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.
Roberts HJ, Ji S, Picca A, Sanson M, Garcia M, Snuderl M, Schüller U, Picart T, Ducray F, Green AL, Nakano Y, Sturm D, Abdullaev Z, Aldape K, Dang D, Kumar-Sinha C, Wu YM, Robinson D, Vo JN, Chinnaiyan AM, Cartaxo R, Upadhyaya SA, Mody R, Chiang J, Baker S, Solomon D, Venneti S, Pratt D, Waszak SM, Koschmann C. Roberts HJ, et al. Among authors: upadhyaya sa. Acta Neuropathol. 2023 Dec;146(6):849-852. doi: 10.1007/s00401-023-02640-7. Epub 2023 Oct 18. Acta Neuropathol. 2023. PMID: 37851269 Free PMC article. No abstract available.
Long-Term Tumor Stability After First-Line Treatment With Larotrectinib in an Infant With NTRK2 Fusion-Positive High-Grade Glioma.
Simoneau J, Robertson P, Muraszko K, Maher CO, Garton H, Calvert R, Koschmann C, Upadhyaya SA, Mody R, Brown N, Kumar-Sinha C, Parmar H, Camelo-Piragua S, Franson AT. Simoneau J, et al. Among authors: upadhyaya sa. J Natl Compr Canc Netw. 2024 Sep;22(7):e247045. doi: 10.6004/jnccn.2024.7045. J Natl Compr Canc Netw. 2024. PMID: 39236755
Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial.
Upadhyaya SA, Robinson GW, Onar-Thomas A, Orr BA, Billups CA, Bowers DC, Bendel AE, Hassall T, Crawford JR, Partap S, Fisher PG, Tatevossian RG, Seah T, Qaddoumi IA, Vinitsky A, Armstrong GT, Sabin ND, Tinkle CL, Klimo P, Indelicato DJ, Boop FA, Merchant TE, Ellison DW, Gajjar A. Upadhyaya SA, et al. Neuro Oncol. 2019 Oct 9;21(10):1319-1330. doi: 10.1093/neuonc/noz069. Neuro Oncol. 2019. PMID: 30976811 Free PMC article. Clinical Trial.
284 results